DanielJosephPiacquadioMD

Dermatology • San Diego, CA

CEO, Therapeutics Inc.

Join to view full profile

Dr. Piacquadio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Piacquadio's full profile

Already have an account?

Office
9025 Balboa Ave
Ste 105
San Diego, CA 92123
Phone+1 858-571-6800

Fax+1 858-571-6801

Education & Training

University of California (San Diego) Medical CenterResidency, Dermatology, 1987 - 1989
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1986 - 1987
Brown UniversityInternship, Internal Medicine, 1984 - 1985
Perelman School of Medicine at the University of PennsylvaniaClass of 1984

Certifications & Licensure

CA State Medical License 1986 - 2025
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand Dermatitis Start of enrollment: 2009 Apr 01
Completed
Phase 2
Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis Start of enrollment: 2011 May 01
Completed
Phase 3
Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis Start of enrollment: 2011 Jun 01
Completed
Phase 3
A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses Start of enrollment: 2011 Feb 01
Completed
Not Applicable
Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat Start of enrollment: 2016 Dec 22
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

62 citations
Reliability of counting actinic keratoses before and after brief consensus discussion : The VA Topical Tretinoin Chemoprevention (VATTC) Trial
Martin A. Weinstock, Stephen F. Bingham, Gary W. Cole, David Eilers, Mark F. Naylor
Archives of Dermatology. 2001-08-01
128 citations
A systematic review of the safety of topical therapies for atopic dermatitis.
J.P. Callen, Sarah L. Chamlin, Lawrence F. Eichenfield, Charles N. Ellis, Michael Girardi
The British Journal of Dermatology. 2007-02-01
64 citations
Super potent topical corticosteroid use associated with adrenal suppression: Clinical considerations
Erik O. Gilbertson, Mary C. Spellman, Daniel Piacquadio, Mim I. Mulford
Journal of the American Academy of Dermatology. 1998-02-01

Professional Memberships

American Academy of Dermatology - AAD
Fellow